Nexalin's device administers a frequency-based waveform that is designed to treat patients in a pain-free and undetectable manner. The Gen-2 and Gen-3 stimulation techniques rely on strategically ...
Nexalin's DIFS treatment improved memory and cognition in Alzheimer's patients, showing significant gains in MMSE and MoCA scores. The 46-patient study revealed increased hippocampal neural activity ...
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has announced the mass production and commercial shipment of the world’s first*1 high-frequency filter using XBAR technology*2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback